Abstract
Objective-Intimal thickening is considered to result from the dedifferentiation of medial smooth muscle cells (SMCs) from a contractile to a synthetic phenotype, and their subsequent migration and proliferation. It is unknown whether nectin-like molecule (Necl)-5, which is overexpressed in cancer cells, is involved in intimal thickening. Approach and Results-Necl-5 was upregulated in mouse carotid artery after ligation. Compared with wild-type mice, intimal thickening after carotid artery ligation was milder in Necl-5 knockout mice. In vitro, the expression levels of SMC differentiation markers were higher, whereas the expression level of an SMC dedifferentiation marker was lower, in Necl-5 knockout mouse aortic SMCs (MASMCs) compared with wild-type MASMCs. The migration, proliferation, and extracellular signal-regulated kinase activity in response to serum were decreased in Necl-5 knockout MASMCs compared with wild-type MASMCs. In wild-type MASMCs, inhibition of extracellular signal-regulated kinase activity increased the expression levels of SMC differentiation markers and decreased their migration and proliferation in response to serum. Conclusions-The present findings indicate that Necl-5 plays a role in the formation of intimal thickening after carotid artery ligation by regulating dedifferentiation, migration, and proliferation of SMCs in an extracellular signal-regulated kinase-dependent manner. Our results suggest that Necl-5 may represent a potential therapeutic target to limit intimal thickening after vascular injury. © 2013 American Heart Association, Inc.
Author supplied keywords
Cite
CITATION STYLE
Kureha, F., Satomi-Kobayashi, S., Kubo, Y., Kinugasa, M., Ishida, T., Takai, Y., … Rikitake, Y. (2013). Nectin-like molecule-5 regulates intimal thickening after carotid artery ligation in mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 33(6), 1206–1211. https://doi.org/10.1161/ATVBAHA.113.301425
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.